CDH1 and prostate cancer: Intriguingly, reconstituted expression of E‐cadherin in E‐cadherin‐negative prostate cancer cells caused the redistribution of β‐catenin to the cell membrane, and consequent reduction of AR‐dependent activity (Yang et al., 2002).